Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced synthesis method for high-purity 3,4-dimethoxy benzenpropanoic acid. Enhances supply chain reliability and reduces environmental impact for pharmaceutical manufacturing.
Patent CN116514707B reveals manganese-catalyzed asymmetric hydrogenation for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability.
Patent CN115785179B reveals a cost-effective oxidation method for high-purity siramectin. Enhance supply chain reliability and reduce manufacturing costs with scalable veterinary drug intermediates.
Patent CN116514707B reveals manganese-catalyzed asymmetric hydrogenation for high-purity pharmaceutical intermediates, offering significant supply chain and cost advantages.
Patent CN111187264A introduces a resin-catalyzed cyclization for mirtazapine, eliminating sulfuric acid waste and simplifying purification for reliable pharmaceutical intermediate supply.
Patent CN101175715B details Rh-catalyzed hydrogenation using PhanePhos for high-purity 3,3-diarylalanine intermediates, offering scalable API synthesis solutions.
Patent CN117362314B enables one-step synthesis via Rh(III) catalysis. Delivers high-purity pharmaceutical intermediates with reduced safety risks and scalable manufacturing efficiency.
Patent CN101323609A details a novel asymmetric oxidation method for high-purity PPI intermediates, offering significant cost reduction and supply chain reliability.
Novel THF-based Grignard route ensures scalable production of anti-ischemia drug intermediates. Eliminates column chromatography for cost-effective supply chain solutions and high purity standards.
Novel chlorobenzene route enhances purity and yield significantly. Reduces steps for pharmaceutical intermediates manufacturing efficiency and supply chain reliability.
Advanced etherification of 3-hydroxymethyl cephalosporins using dioxycarbenium tetrafluoroborate. Superior yield, reduced lactone impurities, and scalable manufacturing solutions.
Patent CN114507177B reveals a base-promoted synthesis route for isoindolinone intermediates using carbon dioxide, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114213365A discloses a high-yield synthetic route for empagliflozin intermediates using mild conditions, offering significant cost reduction in API manufacturing.
Novel chiral resolution method for Tetrabenazine using di-p-methylbenzoyltartaric acid. Achieves >99% ee with scalable crystallization for reliable API intermediate supply.
Patent CN116969919A reveals catalyst-free synthesis of antioxidant intermediates. Offers simplified supply chain and reduced manufacturing costs for pharmaceutical applications.
Patent CN109180407A reveals a novel aldoxime dehydration route. This technology offers significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN113024521B reveals a streamlined 5-step synthesis for Entrectinib, offering high purity and mild conditions for reliable API intermediate supply chains.
Novel patent CN104788357B details cost-effective chiral amino lactam synthesis offering supply chain stability and reduced manufacturing complexity for global partners.
Patent CN112409399B reveals a scalable 3-step synthesis for T541-D, offering high purity and cost reduction in API manufacturing for mTOR inhibitors.
Patent CN105272793B reveals iridium-catalyzed aryl hydrazone synthesis using alcohols. Offers greener, cost-effective alternative to aldehyde condensation for pharmaceutical intermediates.